About Steminent

Better ways to treat diseases, bringing innovation to promote wonderful life



Steminent Biotherapeutics Inc. is a world leading biopharmaceutical company with operations in Taipei and San Diego. With our established cellular platform and technologies, we aimed to develop novel living cellular therapeutics for degenerative diseases and acute, life-threatening diseases.


Steminent seeks to translate our evidence-based technology platform into numerous cellular therapeutic candidates and to advance the clinical potentials through global partnering initiatives. Our ultimate goal is to bring the values to the patients, medical practitioners, our partners as well as shareholders.